About

Discover Our Mission and Vision for Future Success

Founded by Daphne Koller, insitro combines automated high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapeutics.

Core Innovation and Impact Metrics

Discover our key milestones and performance drivers in AI-driven drug discovery.

2018

Founded Year

Established in South San Francisco to revolutionize therapeutics development.

100

Expert Team

Dedicated professionals combining biology and machine learning.

50

Active Programs

Targeted therapies advancing through our automated discovery platform.

Discovering Breakthroughs in Drug Discovery

We combine automated high-throughput cell biology, human genetics, and machine learning to identify causal disease drivers and design targeted therapeutics.

Pioneering AI-Driven Therapeutics for Patients

Founded by Daphne Koller in South San Francisco, insitro integrates robust machine learning with wet lab biology to transform how new medicines are discovered and developed.

Driving Innovation in Modern Biotechnology

Our multidisciplinary team leverages advanced technology platforms to tackle complex diseases and accelerate the path from biological insight to clinical success.

Redefining Research Through Machine Learning

By scaling data generation and predictive modeling, we uncover novel insights that empower our partners to design precision therapies more efficiently.